[HTML][HTML] The displacement of the SARS-CoV-2 variant Delta with Omicron: An investigation of hospital admissions and upper respiratory viral loads

…, CP Morris, JM Norton, DC Gaston… - …, 2022 - thelancet.com
Background The increase in SARS-CoV-2 infections in December 2021 was driven
primarily by the Omicron variant, which largely displaced the Delta over a three-week span. …

Tocilizumab treatment for cytokine release syndrome in hospitalized patients with coronavirus disease 2019: survival and clinical outcomes

…, SE Gleeson, CJ Britto, V Azmy, K Kaman, DC Gaston… - Chest, 2020 - Elsevier
… Britto MD d , Veronica Azmy MD a , Kelsey Kaman MD a , David C. Gaston MD, PhD b ,
Matthew Davis PharmD h , Trisha Burrello MS i , Zachary Harris MD d , Merceditas S. Villanueva …

Evaluation of metagenomic and targeted next-generation sequencing workflows for detection of respiratory pathogens from bronchoalveolar lavage fluid specimens

DC Gaston, HB Miller, JA Fissel, E Jacobs… - Journal of clinical …, 2022 - Am Soc Microbiol
Next-generation sequencing (NGS) workflows applied to bronchoalveolar lavage (BAL)
fluid specimens could enhance the detection of respiratory pathogens, although optimal …

[HTML][HTML] A quick displacement of the SARS-CoV-2 variant delta with omicron: unprecedented spike in COVID-19 cases associated with fewer admissions and …

…, CP Morris, JM Norton, DC Gaston… - MedRxiv, 2022 - ncbi.nlm.nih.gov
Background The increase in SARS-CoV-2 infections in December 2021 in the United States
was driven primarily by the Omicron variant which largely displaced the Delta over a three …

[HTML][HTML] Clinical implications of SARS-CoV-2 cycle threshold values in solid organ transplant recipients

DC Gaston, M Malinis, R Osborn, DR Peaper… - American Journal of …, 2021 - Elsevier
Detection of SARS-CoV-2 viral RNA by RT-PCR assays is the primary diagnostic test for
COVID-19. Cycle threshold (C T ) values generated by some of these assays provide inversely …

Impact of severe acute respiratory syndrome coronavirus 2 variants on inpatient clinical outcome

…, RE Eldesouki, JM Norton, DC Gaston… - Clinical Infectious …, 2023 - academic.oup.com
Background Prior observation has shown differences in COVID-19 hospitalization risk
between SARS-CoV-2 variants, but limited information describes hospitalization outcomes. …

Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) delta variant is associated with higher recovery of infectious virus compared to the …

…, A Amadi, DC Gaston… - Clinical Infectious …, 2022 - academic.oup.com
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of
concern (VOC) B.1.617.2 (Delta) displaced B.1.1.7 (Alpha) and is associated with increases …

Combination therapy with casirivimab/imdevimab and remdesivir for protracted SARS-CoV-2 infection in B-cell-depleted patients

MV Dioverti, DC Gaston, CP Morris… - Open forum …, 2022 - academic.oup.com
Profoundly B-cell-depleted patients can have prolonged severe acute respiratory syndrome
coronavirus 2 infections with evidence of active viral replication, due to inability to mount an …

Clinical metagenomics for infectious diseases: progress toward operational value

DC Gaston - Journal of Clinical Microbiology, 2023 - Am Soc Microbiol
The field of clinical metagenomics for infectious disease diagnostics has advanced to combining
questions of technical methodologies with best-use practices due to lowering barriers of …

Tocilizumab treatment for cytokine release syndrome in hospitalized patients with coronavirus disease 2019.

…, SE Gleeson, CJ Britto, V Azmy, K Kaman, DC Gaston… - 2020 - cabidigitallibrary.org
Background: Tocilizumab, an IL-6 receptor antagonist, can be used to treat cytokine release
syndrome (CRS), with observed improvements in a coronavirus disease 2019 (COVID-19) …